From MedTech Europe - please provide any comments to neil.plumridge@bivda.org.uk. With this email, we would like to inform you about the latest chemical developments at ECHA and kindly ask you to indicate if any of the following impacts your company by 19 November. Please note that the substances highlighted in yellow are the ones already present in the substance tracker…
Ben KempNovember 13, 2025